Latest Breaking News On - Amplyx pharmaceuticals - Page 1 : comparemela.com

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Robertm brennerJoyce allaireMari purpuraMarshall fordyceWilliamd turnerAmplyx pharmaceuticals incPfizer incEuropean renal association congressExchange commissionVera therapeutics incRecent business highlightsChief medical officerChief developmentQuarter ended marchB cell activating factorInducing ligand

Vera Therapeutics : Provides Business Update and Reports First Quarter 2024 Financial Results - Form 8-K

Vera Therapeutics : Provides Business Update and Reports First Quarter 2024 Financial Results - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Marshall fordyceWilliamd turnerMari purpuraJoyce allaireRobertm brennerAmplyx pharmaceuticals incPfizer incVera therapeutics incEuropean renal association congressExchange commissionVera therapeutics provides business updateReports first quarterRecent business highlightsChief medical officerChief development officerQuarter ended march

Candidemia Market Size, Growth, Industry Trends And Forecast Report 2024-2034

Candidemia Market Size, Growth, Industry Trends And Forecast Report 2024-2034
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAmplyx pharmaceuticalsMarket sizeMarket trendsCovered across each countryMarket drugsMarket performanceStage pipeline drugsKey players

Pfizer cuts 3 assets as R&D spend drops 24% in Q4

Pfizer cuts 3 assets as R&D spend drops 24% in Q4
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

David dentonAmplyx pharmaceuticalsNew york basedChief financial officerBig pharma

Basilea announces acquisition of fosmanogepix, a phase-3-ready broad-spectrum antifungal

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting.

Basel stadtSwitzerland generalUnited statesDavid veitchCresemba zevteraNils schrDrug administrationAmplyx pharmaceuticals incSwiss exchangeHead of corporate communications investor relationsAmerican thoracic societyBasilea pharmaceutica international ltdBasilea pharmaceutica ltdPfizer incPharmaceutica ltdAmplyx pharmaceuticals